Human T-lymphotropic virus 1
"Human T-lymphotropic virus 1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A strain of PRIMATE T-LYMPHOTROPIC VIRUS 1 isolated from mature T4 cells in patients with T-lymphoproliferation malignancies. It causes adult T-cell leukemia (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED), T-cell lymphoma (LYMPHOMA, T-CELL), and is involved in mycosis fungoides, SEZARY SYNDROME and tropical spastic paraparesis (PARAPARESIS, TROPICAL SPASTIC).
| Descriptor ID |
D015368
|
| MeSH Number(s) |
B04.613.807.200.725.400 B04.820.650.200.725.400
|
| Concept/Terms |
Human T-lymphotropic virus 1- Human T-lymphotropic virus 1
- Human T lymphotropic virus 1
- Leukemia Lymphoma Virus I, Adult T Cell
- Adult T-Cell Leukemia-Lymphoma Virus I
- ATLV
- HTLV-I
- Human T Cell Leukemia Virus I
- HTLV-1
- T Cell Leukemia Virus I, Human
- Human T-Cell Leukemia Virus I
- Leukemia Virus I, Human T-Cell
- T-Cell Leukemia Virus I, Human
- Adult T Cell Leukemia Lymphoma Virus I
- Leukemia Virus I, Human T Cell
|
Below are MeSH descriptors whose meaning is more general than "Human T-lymphotropic virus 1".
Below are MeSH descriptors whose meaning is more specific than "Human T-lymphotropic virus 1".
This graph shows the total number of publications written about "Human T-lymphotropic virus 1" by people in this website by year, and whether "Human T-lymphotropic virus 1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 1 | 2 |
| 1996 | 6 | 0 | 6 |
| 1997 | 5 | 0 | 5 |
| 1998 | 3 | 0 | 3 |
| 1999 | 4 | 0 | 4 |
| 2000 | 7 | 0 | 7 |
| 2001 | 3 | 1 | 4 |
| 2002 | 2 | 1 | 3 |
| 2003 | 2 | 0 | 2 |
| 2004 | 4 | 0 | 4 |
| 2005 | 6 | 2 | 8 |
| 2006 | 5 | 0 | 5 |
| 2007 | 3 | 2 | 5 |
| 2008 | 1 | 2 | 3 |
| 2009 | 0 | 1 | 1 |
| 2011 | 2 | 2 | 4 |
| 2012 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2021 | 2 | 0 | 2 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Human T-lymphotropic virus 1" by people in Profiles.
-
Isolated cardiac valve involvement in smoldering adult T-cell leukemia/lymphoma. Cardiovasc Pathol. 2023 May-Jun; 64:107513.
-
An international, multicenter, retrospective study on the positive impact of cutaneous involvement on the clinical outcome of adult T-cell leukemia/lymphoma. Leuk Lymphoma. 2022 02; 63(2):315-325.
-
Case Report: HTLV-1-Induced Adult T-Cell Leukemia and Tropical Spastic Paresis. Am J Trop Med Hyg. 2021 09 20; 105(5):1298-1300.
-
Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma. Br J Haematol. 2018 11; 183(3):428-444.
-
HTLV-1 Tax plugs and freezes UPF1 helicase leading to nonsense-mediated mRNA decay inhibition. Nat Commun. 2018 01 30; 9(1):431.
-
FACT Proteins, SUPT16H and SSRP1, Are Transcriptional Suppressors of HIV-1 and HTLV-1 That Facilitate Viral Latency. J Biol Chem. 2015 Nov 06; 290(45):27297-27310.
-
HTLV-1-associated infective dermatitis demonstrates low frequency of FOXP3-positive T-regulatory lymphocytes. J Dermatol Sci. 2015 Mar; 77(3):150-5.
-
Viral lymphomagenesis: from pathophysiology to the rationale for novel therapies. Br J Haematol. 2014 May; 165(3):300-15.
-
Lack of recall response to Tax in ATL and HAM/TSP patients but not in asymptomatic carriers of human T-cell leukemia virus type 1. J Clin Immunol. 2013 Oct; 33(7):1223-39.
-
Activation of WIP1 phosphatase by HTLV-1 Tax mitigates the cellular response to DNA damage. PLoS One. 2013; 8(2):e55989.